Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03565211 · ClinicalTrials.gov registry record · Phase 3
Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures
A Phase 3 study, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 352
- Enrollment target
NCT03565211 is a Phase 3 study that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 352 participants.
The verdict
NCT03565211, a Phase 3 study, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 352 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the safety of Progesterone Vaginal Ring (PVR) in women undergoing fresh embryo transfer (ART).
Interventions
- DRUG Progesterone vaginal ring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2018-07-26 |
| Est. Completion | 2019-07-29 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03565211
The ClinicalTrials.gov registry entry for NCT03565211 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 352 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Progesterone vaginal ring is the first listed.
NCT03565211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03565211 about?
NCT03565211 is a clinical study titled "Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures". The purpose of the study is to assess the safety of Progesterone Vaginal Ring (PVR) in women undergoing fresh embryo transfer (ART).
What is the current status of trial NCT03565211?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 352 participants. The study started on 2018-07-26. Estimated completion is 2019-07-29.
What interventions are being tested in trial NCT03565211?
The interventions under investigation include: Progesterone vaginal ring (DRUG).
Who is sponsoring clinical trial NCT03565211?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.